"The justices think we are living in a post-racial America and nothing could be further from the truth," one medical school president said.June 29, 2023Check out STAT+Sponsored By STEFANI REYNOLDS/AFP via Getty Images Medical leaders decry Supreme Court decision on affirmative action "The justices think we are living in a post-racial America and nothing could be further from the truth," one medical school president said. By Usha Lee McFarling STAT+ | Counter-culture or pharma: Group behind MDMA therapy for PTSD wrestles with its identity With MDMA nearing approval for PTSD, the Multidisciplinary Association for Psychedelic Studies faces the pressures of operating as a pharma firm. By Olivia Goldhill Walensky prepares to leave CDC — and Congress — after a bruising 29 months The outgoing CDC director spoke with STAT about her bruising 29 months, and the reforms she believes will set the agency on a better path. By Helen Branswell Courtesy Sarah McCarthy Opinion: The love my daughter and I found in the PICU Love exists in the PICU, and continuous care staffing policies may make it easier for this love to surround those who so desperately need it. By Sarah McCarthy Stop taking Ozempic before surgery, anesthesiologist group recommends New guidance raised concerns that delayed stomach emptying on these drugs could raise the risk of food getting into lungs during surgery. By Elaine Chen We have a cure for hepatitis C — so why aren't more people getting treatment? Only 1 out of 3 adults diagnosed with hepatitis C have been cured since 2013, when highly effective drugs became available in the U.S. By Abdullahi Tsanni Sammy Kimball for STAT Listen: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market This episode, the new Novavax CEO discusses his plan to right the ship at a company that has struggled to make the most of its Covid vaccine. By Damian Garde and Meg Tirrell and Adam Feuerstein STAT+ | Alkermes shareholders re-elect directors, rebuffing effort by hedge fund Sarissa At the company's annual meeting, shareholders voted in favor of Alkermes' proposal to retain all seven of the director nominees to the board. By Adam Feuerstein and Damian Garde More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments